Diabetic gastroparesis is a condition that causes frequent nausea and vomiting, which has a negative impact on quality of life and poses a significant burden on the healthcare system. Metoclopramide is a dopamine antagonist used to treat nausea and vomiting that may be associated with diabetic gastroparesis in addition to gastroesophageal reflux disease (GER...
Metoclopramide in the oral tablet form is used for symptomatic treatment of both acute and recurrent diabetic gastroparesis, in addition to the treatment of gastroesophageal reflux disease (GERD) in patients who have failed to respond to traditional therapy. A nasal spray formulation is also indicated to treat adults with acute, recurrent diabetic gastropare...
Franklin Gastroenterology, PLLC, Franklin, Tennessee, United States
Indiana University Hospital, Indianapolis, Indiana, United States
Pinnacle Research Group, LLC, Anniston, Alabama, United States
Brigham and Women's Hospital, Boston, Massachusetts, United States
Jamaica Hospital Medical Center, Jamaica, New York, United States
Virginia Tech Carilion School of Medicine, Roanoke, Virginia, United States
Mercy Facial Plastic Surgery Center, Springfield, Missouri, United States
Saint Louis University, Saint Louis, Missouri, United States
Mount Sinai Hospital, Toronto, Ontario, Canada
Be'er Sheva Mental Health Center,, Be'er Sheva, Israel
University of Rochester, Rochester, New York, United States
University at Buffalo, Buffalo, New York, United States
Tergooiziekenhuizen, Hilversum, Noord Holland, Netherlands
Rijnstate, Arnhem, Netherlands
Medisch Centrum Alkmaar, Alkmaar, Noord-Holland, Netherlands
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.